Research Article
Volume 7 Issue 9 - 2020
Clinical Outcomes of Biodegradable Polymer Sirolimus-Eluting Stent in Coronary Artery Lesions Patients: A Retrospective Analysis
Binu Thankappan Gomathy*
Padmavathy Medical Foundation, Sasthamkotta, Kollam, Kerala, India
*Corresponding Author: Binu Thankappan Gomathy, Padmavathy Medical Foundation, Sasthamkotta, Kollam, Kerala, India.
Received: March 18, 2020; Published: August 31, 2020




Abstract

The aim of this study was to evaluate the safety and efficacy of biodegradable polymer BioMime™ sirolimus-eluting coronary stent (SES) for the treatment of coronary artery disease. This was a retrospective analysis of 73consecutive patients who underwent percutaneous coronary intervention with BioMime SES implantation were included. The clinical endpoint was a major adverse cardiac event (MACE) including cardiac death, myocardial infarction (MI) and target lesion revascularization. The mean patient age was 61.3 ± 12.2 years and 62 (84.9%) were male. A total of 139 lesions were intervened successfully with 73 stents. The average stent length and diameter was 24.4 ± 8.38 mm and 2.79 ± 0.27 mm respectively. The patients characteristics were noted as having 28 (38.4%) diabetics and 36 (49.3%) hypertensive patients. Device and procedural success was 100%. During a mean follow-up at 1.68 ± 0.58 years, the absence of MACE was observed. No stent thrombosis or MI was reported. The present study demonstrated the BioMime SES is safe and effective in "real-world" coronary artery disease patients population.

Keywords: Biodegradable Polymer; Percutaneous Coronary Intervention; Sirolimus-Eluting Stent

References

  1. Ma X., et al. “Drug-eluting stent coatings”. Interventional Cardiology 4 (2012): 73-83.
  2. Ishii H., et al. “Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients”. Circulation Journal: Official Journal of the Japanese Circulation Society 76 (2012): 1609-1615.
  3. Yildiz M., et al. “Recent Developments in Drug-Eluting Coronary Stents”. Cardiovascular and Haematological Disorders 14 (2014): 220-224.
  4. Navarese EP., et al. “First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients”. Open Heart (2014).
  5. Jaffery Z., et al. “Drug-eluting coronary stents - focus on improved patient outcomes”. Patient Related Outcome Measures 2 (2011): 161-174.
  6. Morice M-C., et al. “A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization”. The New England Journal of Medicine 346 (2002): 1773-1780.
  7. Moses JW., et al. “Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery”. The New England Journal of Medicine 349 (2003): 1315-1323.
  8. Lemos PA., et al. “Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry”. Circulation 109 (2004): 190-195.
  9. Stettler C., et al. “Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis”. The Lancet 370 (2007): 937-948.
  10. Spaulding C., et al. “A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents”. The New England Journal of Medicine 356 (2007): 989-997.
  11. Hamon M., et al. “Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study”. EuroIntervention 8 (2013): 1006-1011.
  12. Seth A., et al. “Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt–chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial”. AsiaIntervention 2 (2016): 19-27.
  13. Dani S., et al. “First-in-human evaluation of the novel Bio Mime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial”. EuroIntervention 9 (2013): 493-500.
  14. Levine GN., et al. “2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions”. Catheterization and Cardiovascular Interventions (2015).
  15. Cutlip DE., et al. “Clinical End Points in Coronary Stent Trials. A Case for Standardized Definitions”. Circulation 115 (2007): 2344-2351.
  16. Dani S., et al. “First-in-human evaluation of the novel Bio Mime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels-results from the meriT-1 trial”. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 9 (2013): 493-500.
  17. Alaswad K., et al. “Transradial approach for coronary chronic total occlusion interventions: insights from a contemporary multicenter registry”. Catheterization and Cardiovascular Interventions 85 (2015): 1123-1129.
  18. Colombo A., et al. “Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions”. Circulation 108 (2003): 788-794.
  19. Kastrati A., et al. “ [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial] ”. Vestnik Rentgenologii i Radiologii (2012): 52-60.
  20. Pache J., et al. “Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial”. Journal of the American College of Cardiology 41 (2003): 1283-1288.
  21. Wang G., et al. “First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1”. Catheterization and Cardiovascular Interventions 85 (2015): 744-751.
  22. Xu K., et al. “Efficacy and Safety of A Second Generation Biodegradable‐Polymer Sirolimus‐Eluting Stent: One Year Results of The CREDIT 2 Trial”. Cardiovascular Therapeutics 3 (2018): e12327.
  23. Simon C., et al. “Influence of topography on endothelialization of stents: clues for new designs”. Journal of Long-Term Effects of Medical Implants (2000): 10.
  24. Lekshmi KM., et al. “Drug- and Gene-eluting Stents for Preventing Coronary Restenosis”. Chonnam Medical Journal 53 (2017): 14-27.
  25. Costa JJ., et al. “EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions”. EuroIntervention 4 (2008): 53-58.
  26. Taniwaki M., et al. “4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention) ”. Journal of the American College of Cardiology 63 (2014): 1617-1625.
  27. Pilgrim T., et al. “Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial”. The Lancet 384 (2014): 2111-2122.
  28. Waksman R., et al. “Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice”. The American Journal of Cardiology 109 (2012): 1288-1294.
  29. Stone GW., et al. “Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial”. Journal of the American Medical Association 299 (2008): 1903-1913.
  30. Danzi GB., et al. “Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study”. EuroIntervention 8 (2012): 109-116.
  31. Seth A., et al. “Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels: results from the prospective, multicentre meriT-2 clinical trial”. Asia Intervention 2 (2016): 19-27.
  32. Jain RK., et al. “One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study”. Indian Heart Journal 68 (2016): 599-603.
Citation: Binu Thankappan Gomathy. “Clinical Outcomes of Biodegradable Polymer Sirolimus-Eluting Stent in Coronary Artery Lesions Patients: A Retrospective Analysis”. EC Cardiology 7.9 (2020): 07-13.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


June Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the June issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before June 30, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk